Dr. Michael O. Thorner
Biography & Research Background
Michael O. Thorner, MB, BS, DSc, is Professor Emeritus at the University of Virginia. He led the Geref International Study Group multicenter trials that established Sermorelin's efficacy in pediatric GHD. A pioneer in GHRH discovery, his work spans from the original characterization of GHRH to modern growth hormone secretagogue research for aging. Michael O. Thorner is being referenced as one of the leading scientists involved in the research and development of Sermorelin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Michael O. Thorner is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Michael O. Thorner is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.